Fei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fei Wang has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Hao Lu
School of Medicine Xiamen University Xiamen China
2 shared publicationsJigong Wu
Department of Spine Surgery The Ninth Medical Center of PLA General Hospital Beijing China
2 shared publicationsShibo Huang
Department of Spine Surgery The Ninth Medical Center of PLA General Hospital Beijing China
2 shared publicationsYouping Tao
Department of Spine Surgery The Ninth Medical Center of PLA General Hospital Beijing China
2 shared publicationsYu Cao
School of Medicine Xiamen University Xiamen China
2 shared publicationsYuehan Pan
Key Laboratory of Orogenic Belts and Crustal Evolution Department of Geology Peking University Beijing China
2 shared publications
Latest Publications
- 19 February 2025
- Published by Wiley in Musculoskeletal Care
- Vol. 23 (1) , e70056
Low Back Pain Incidence Trends Globally, Regionally, and Nationally, 1990–2019: An Age‐Period‐Cohort Analysis, Cross‐Sectional Studies
Introduction: Low back pain (LBP) imposes a significant burden on global health, yet it remains deficient in comprehensive investigations pertaining to its incidence patterns. The aim of this study was to analyse global, regional and national trends and associated factors in the incidence of LBP from 1990–2019.Methods: In order to examine global and country‐specific 30‐year incidence patterns of LBP, data were obtained from the 2019 Global Burden of Disease Study. An age‐period cohort (APC) model was utilised to determine annual percent changes, age‐specific changes, and period/cohort effects.Results: The age‐standardized global LBP incidence rate significantly declined from 1990–2019. However, the absolute number of cases increased by 2.39 billion, predominantly in middle‐, low‐middle‐ and low‐socio‐demographic index (SDI) regions, affecting mostly 50–69 years old with a higher incidence in women. LBP incidence increased progressively from low to high SDI regions. Period and cohort effects trended downward in all regions except high‐SDI countries, which had the lowest incidence decline and a slight rebound after 2012.Conclusions: Our study updates global and regional LBP incidence from 1990–2019 using APC modelling, showing declining age‐standardized rates globally but increased case numbers due to population growth and ageing. Prevention likely helped reduce incidence, but more health strengthening and minimally invasive treatments are still needed, especially where LBP has plateaued or rebounded recently.
- 19 February 2025
- Published by Wiley in Musculoskeletal Care
- Vol. 23 (1) , e70056
Low Back Pain Incidence Trends Globally, Regionally, and Nationally, 1990–2019: An Age‐Period‐Cohort Analysis, Cross‐Sectional Studies
Introduction: Low back pain (LBP) imposes a significant burden on global health, yet it remains deficient in comprehensive investigations pertaining to its incidence patterns. The aim of this study was to analyse global, regional and national trends and associated factors in the incidence of LBP from 1990–2019.Methods: In order to examine global and country‐specific 30‐year incidence patterns of LBP, data were obtained from the 2019 Global Burden of Disease Study. An age‐period cohort (APC) model was utilised to determine annual percent changes, age‐specific changes, and period/cohort effects.Results: The age‐standardized global LBP incidence rate significantly declined from 1990–2019. However, the absolute number of cases increased by 2.39 billion, predominantly in middle‐, low‐middle‐ and low‐socio‐demographic index (SDI) regions, affecting mostly 50–69 years old with a higher incidence in women. LBP incidence increased progressively from low to high SDI regions. Period and cohort effects trended downward in all regions except high‐SDI countries, which had the lowest incidence decline and a slight rebound after 2012.Conclusions: Our study updates global and regional LBP incidence from 1990–2019 using APC modelling, showing declining age‐standardized rates globally but increased case numbers due to population growth and ageing. Prevention likely helped reduce incidence, but more health strengthening and minimally invasive treatments are still needed, especially where LBP has plateaued or rebounded recently.
- 6 February 2025
- Published by Wiley in Musculoskeletal Care
- Vol. 23 (1) , e70045
Osteoarthritis Incidence Trends Globally, Regionally, and Nationally, 1990–2019: An Age‐Period‐Cohort Analysis
Objectives: Osteoarthritis (OA) contributes substantially to global disability. We analysed global and national OA incidence trends and associated factors.Methods: Data obtained from the 2019 Global Burden of Disease Study were used to examine 30‐year OA incidence patterns globally and for 204 countries/territories. An age‐period‐cohort (APC) model determined annual percent changes, age‐specific changes, and period/cohort effects.Results: From 1990 to 2019, global OA incidence rose by 21.3 million, with the highest cases in China, India, the United States, and Japan. Incidence was higher in women versus men and peaked at ages 20–24 years, though shifting towards middle‐aged adults. The annual increase was 0.225% (95% confidence interval [CI] 0.157, 0.293) and 0.158% (95% CI: 0.114, 0.201) in high and low socio‐demographic index countries, respectively, with most countries showing increasing incidence. Disadvantageous incidence trends over time and birth cohorts occurred in all regions except middle‐high index countries, which had the lowest increase and declining period effect after 2005.Conclusion: OA represents an escalating public health burden, predominantly affecting middle‐aged and elderly populations, and more women than men. Obesity and ageing are major drivers of rising OA incidence. Swiftly implementing policies to prevent modifiable risks and ensure proper treatment access is imperative to mitigate the impact of OA.
- 6 February 2025
- Published by Wiley in Musculoskeletal Care
- Vol. 23 (1) , e70045
Osteoarthritis Incidence Trends Globally, Regionally, and Nationally, 1990–2019: An Age‐Period‐Cohort Analysis
Objectives: Osteoarthritis (OA) contributes substantially to global disability. We analysed global and national OA incidence trends and associated factors.Methods: Data obtained from the 2019 Global Burden of Disease Study were used to examine 30‐year OA incidence patterns globally and for 204 countries/territories. An age‐period‐cohort (APC) model determined annual percent changes, age‐specific changes, and period/cohort effects.Results: From 1990 to 2019, global OA incidence rose by 21.3 million, with the highest cases in China, India, the United States, and Japan. Incidence was higher in women versus men and peaked at ages 20–24 years, though shifting towards middle‐aged adults. The annual increase was 0.225% (95% confidence interval [CI] 0.157, 0.293) and 0.158% (95% CI: 0.114, 0.201) in high and low socio‐demographic index countries, respectively, with most countries showing increasing incidence. Disadvantageous incidence trends over time and birth cohorts occurred in all regions except middle‐high index countries, which had the lowest increase and declining period effect after 2005.Conclusion: OA represents an escalating public health burden, predominantly affecting middle‐aged and elderly populations, and more women than men. Obesity and ageing are major drivers of rising OA incidence. Swiftly implementing policies to prevent modifiable risks and ensure proper treatment access is imperative to mitigate the impact of OA.
- Open Access
- 6 November 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-18
Immune inhibitory receptor-mediated immune response, metabolic adaptation, and clinical characterization in patients with COVID-19
Immune inhibitory receptors (IRs) play a critical role in the regulation of immune responses to various respiratory viral infections. However, in coronavirus disease 2019 (COVID-19), the roles of these IRs in immune modulation, metabolic reprogramming, and clinical characterization remain to be determined. Through consensus clustering analysis of IR transcription in the peripheral blood of patients with COVID-19, we identified two distinct IR patterns in patients with COVID-19, which were named IR_cluster1 and IR_cluster2. Compared to IR_cluster1 patients, IR_cluster2 patients with lower expressions of immune inhibitory receptors presented with a suppressed immune response, lower nutrient metabolism, and worse clinical manifestations or prognosis. Considering the critical influence of the integrated regulation of multiple IRs on disease severity, we established a scoring system named IRscore, which was based on principal component analysis, to evaluate the combined effect of multiple IRs on the disease status of individual patients with COVID-19. Similar to IR_cluster2 patients, patients with high IRscores had longer hospital-free days at day 45, required ICU admission and mechanical ventilatory support, and presented higher Charlson comorbidity index and SOFA scores. A high IRscore was also linked to acute infection phase and absence of drug intervention. Our investigation comprehensively elucidates the potential role of IR patterns in regulating the immune response, modulating metabolic processes, and shaping clinical manifestations of COVID-19. All of this evidence suggests the essential role of prognostic stratification and biomarker screening based on IR patterns in the clinical management and drug development of future emerging infectious diseases such as COVID-19.
- 6 November 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-18
Open AccessImmune inhibitory receptor-mediated immune response, metabolic adaptation, and clinical characterization in patients with COVID-19
Immune inhibitory receptors (IRs) play a critical role in the regulation of immune responses to various respiratory viral infections. However, in coronavirus disease 2019 (COVID-19), the roles of these IRs in immune modulation, metabolic reprogramming, and clinical characterization remain to be determined. Through consensus clustering analysis of IR transcription in the peripheral blood of patients with COVID-19, we identified two distinct IR patterns in patients with COVID-19, which were named IR_cluster1 and IR_cluster2. Compared to IR_cluster1 patients, IR_cluster2 patients with lower expressions of immune inhibitory receptors presented with a suppressed immune response, lower nutrient metabolism, and worse clinical manifestations or prognosis. Considering the critical influence of the integrated regulation of multiple IRs on disease severity, we established a scoring system named IRscore, which was based on principal component analysis, to evaluate the combined effect of multiple IRs on the disease status of individual patients with COVID-19. Similar to IR_cluster2 patients, patients with high IRscores had longer hospital-free days at day 45, required ICU admission and mechanical ventilatory support, and presented higher Charlson comorbidity index and SOFA scores. A high IRscore was also linked to acute infection phase and absence of drug intervention. Our investigation comprehensively elucidates the potential role of IR patterns in regulating the immune response, modulating metabolic processes, and shaping clinical manifestations of COVID-19. All of this evidence suggests the essential role of prognostic stratification and biomarker screening based on IR patterns in the clinical management and drug development of future emerging infectious diseases such as COVID-19.
- 1 February 2020
- Published by Elsevier in Aquaculture
- Vol. 516, 734645
Baicalin attenuates Streptococcus agalactiae virulence and protects tilapia (Oreochromis niloticus) from group B streptococcal infection
- 1 February 2020
- Published by Elsevier in Aquaculture
- Vol. 516, 734645
Baicalin attenuates Streptococcus agalactiae virulence and protects tilapia (Oreochromis niloticus) from group B streptococcal infection
- Open Access
- 1 January 2018
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 14 (2) , 147-155
NLRP12 Promotes Mouse Neutrophil Differentiation through Regulation of Non-canonical NF-κB and MAPKERK1/2 Signaling
Neutrophils are the most important component of the innate immune system. Mechanistic understanding of the mechanism underlying neutrophil differentiation remains elusive. Using genome-wide RNA-seq, we identified genes whose expression is dramatically up-regulated during neutrophil differentiation. Among them is nucleotide-binding leucine-rich repeat and pyrindomain-containing receptor 12 (NLRP12), which plays a role in immune inflammatory responses. Genetic ablation of NLRP12 suppresses NF-κB inducing kinase (NIK) stabilization, RelB nuclear translocation and neutrophil differentiation in vitro. At a mechanistic level, NLRP12 inhibits the activity of mitogen-activated protein kinases (MAPK)/extracellular signal-regulated kinases (ERK1/2), relieves ERK1/2 suppression of NIK protein levels. Thus, NLRP12 enhances noncanonical NF-κB signaling through inhibition of ERK1/2 signaling, thereby promoting neutrophil differentiation.
- 1 January 2018
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 14 (2) , 147-155
Open AccessNLRP12 Promotes Mouse Neutrophil Differentiation through Regulation of Non-canonical NF-κB and MAPKERK1/2 Signaling
Neutrophils are the most important component of the innate immune system. Mechanistic understanding of the mechanism underlying neutrophil differentiation remains elusive. Using genome-wide RNA-seq, we identified genes whose expression is dramatically up-regulated during neutrophil differentiation. Among them is nucleotide-binding leucine-rich repeat and pyrindomain-containing receptor 12 (NLRP12), which plays a role in immune inflammatory responses. Genetic ablation of NLRP12 suppresses NF-κB inducing kinase (NIK) stabilization, RelB nuclear translocation and neutrophil differentiation in vitro. At a mechanistic level, NLRP12 inhibits the activity of mitogen-activated protein kinases (MAPK)/extracellular signal-regulated kinases (ERK1/2), relieves ERK1/2 suppression of NIK protein levels. Thus, NLRP12 enhances noncanonical NF-κB signaling through inhibition of ERK1/2 signaling, thereby promoting neutrophil differentiation.
- 1 September 2013
- Published by Elsevier in Developmental & Comparative Immunology
- Vol. 41 (1) , 1-10
Molecular and cellular analyses of a ryanodine receptor from hemocytes of Pieris rapae
- 1 September 2013
- Published by Elsevier in Developmental & Comparative Immunology
- Vol. 41 (1) , 1-10
Molecular and cellular analyses of a ryanodine receptor from hemocytes of Pieris rapae
- Open Access
- 6 December 2012
- Published by American Society of Hematology in Blood
- Vol. 120 (24) , 4712-4719
Identification of key regulatory pathways of myeloid differentiation using an mESC-based karyotypically normal cell model
Understanding the process of myeloid differentiation offers important insights into both normal and abnormal developmental processes but is limited by the dearth of experimental models. Here we show that myeloid progenitors can be derived from embryonic stem cells, immortalized, and applied to the study of the mechanisms underlying myeloid differentiation. The embryonic stem cell–derived myeloid progenitors, when immortalized with estrogen-regulated Hoxb8 protein, demonstrate normal karyotyping, are genetically tractable, and can be differentiated into functional neutrophils. Using this model, we identified mammalian target of rapamycin complex 1 as a critical regulator of myeloid differentiation. Together, our studies led to a convenient, karyotypically normal, and genetically manipulatable cellular system, which can be used to shed new light on the mechanisms for myeloid differentiation.
- 6 December 2012
- Published by American Society of Hematology in Blood
- Vol. 120 (24) , 4712-4719
Open AccessIdentification of key regulatory pathways of myeloid differentiation using an mESC-based karyotypically normal cell model
Understanding the process of myeloid differentiation offers important insights into both normal and abnormal developmental processes but is limited by the dearth of experimental models. Here we show that myeloid progenitors can be derived from embryonic stem cells, immortalized, and applied to the study of the mechanisms underlying myeloid differentiation. The embryonic stem cell–derived myeloid progenitors, when immortalized with estrogen-regulated Hoxb8 protein, demonstrate normal karyotyping, are genetically tractable, and can be differentiated into functional neutrophils. Using this model, we identified mammalian target of rapamycin complex 1 as a critical regulator of myeloid differentiation. Together, our studies led to a convenient, karyotypically normal, and genetically manipulatable cellular system, which can be used to shed new light on the mechanisms for myeloid differentiation.